JPMorgan cuts Syndax Pharmaceuticals target price to $24 from $40
SNDX•JPMorgan cut its target price on Syndax Pharmaceuticals to $24 from $40.
Related News

Telkom Indonesia unit Telkom Akses eyes digital public services partnership in East Nusa Tenggara
TLK•

Loblaw Companies raises target price to C$84 from C$83
L•

Top stories for November 20
NVDA•

Oil prices gain as Houthi attacks on Riyadh raise supply concerns
USO•

Gold set for worst week in eight months as firm dollar, Fed hike bets weigh
GLD•